Press Releases | Mylan MediaRoom Launch of Generic Lialda® Delayed-Release Tablets Expands Mylan's Gastroenterology Product Offering Mesalamine Delayed-Release Tablets help individuals manage their ulcerative colitis. Mon, 17 Dec 2018 10:45:00 -0500 Mylan Adds First Generic for Canasa® Rectal Suppository to Growing Gastroenterology Portfolio Mylan's Mesalamine Rectal Suppository treats mildly to moderately active ulcerative proctitis Mon, 17 Dec 2018 10:30:00 -0500 Sanofi's Formulation Patents on Multibillion-Dollar Lantus® are Invalidated by U.S. Patent and Trademark Office via IPR, Announces Mylan Mylan achieves key milestone to provide U.S. diabetes patients with more affordable generic version of Sanofi's Lantus® insulin glargine vials Thu, 13 Dec 2018 07:30:00 -0500 Mylan Expands its Voluntary Nationwide Recall of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, to All Lots Within Expiry Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient Tue, 04 Dec 2018 11:30:00 -0500 Mylan Expands Gastroenterology Portfolio with Launch of Generic for Prevacid® SoluTab Delayed-Release Orally Disintegrating Tablets Mylan's Lansoprazole Delayed-Release Orally Disintegrating Tablets are approved to treat certain types of gastrointestinal ulcers Tue, 04 Dec 2018 07:30:00 -0500